Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $274,854 - $359,485
-3,152 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$94.19 - $124.49 $8,288 - $10,955
88 Added 2.87%
3,152 $350,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $7,891 - $9,178
66 Added 2.2%
3,064 $392,000
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $23,689 - $30,889
217 Added 7.8%
2,998 $399,000
Q2 2021

Aug 09, 2021

BUY
$100.34 - $115.69 $903 - $1,041
9 Added 0.32%
2,781 $301,000
Q1 2021

May 10, 2021

SELL
$101.51 - $125.27 $1,218 - $1,503
-12 Reduced 0.43%
2,772 $292,000
Q4 2020

Jan 29, 2021

BUY
$85.88 - $105.36 $239,089 - $293,322
2,784 New
2,784 $290,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Epg Wealth Management LLC Portfolio

Follow Epg Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epg Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epg Wealth Management LLC with notifications on news.